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The reaction of Fe(II1) cytochrome P450 cm with m-chloroperbenzoic acid was studied by rapid scanning 
absorption spectroscopy. Native low-spin enzyme produced spectra characteristic of two reaction phases 
that were marked by time intervals with isosbestic positions. The high-spin enzyme substrate complex 
yielded a series of Soret-region spectra whose properties were dependent on peracid concentration. The 
simplest model describing the results was a sequence of at least wo spectral intermediates, that were not 
entirely homologous with data measured inreactions with microsomal P450LMz. Comparisons with related 
heme protein states indicate higher Fe(IV) oxidation levels provide a plausible interpretation of the 
P450cAM spectra. 
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1. INTRODUCTION 
The P450 cytochromes are a substrate-diverse 
class of b-type heme monoxygenases [ 1,2], whose 
structural and functional properties are well 
represented by the bacterial cytochrome P45oCAM 
model system [3,4]. Cytochrome P45OCAM cata- 
lyzes a two-electron activation of 02 resulting in 
the 5-exe-hydroxylation of camphor. In the overall 
rate-limiting step of this process, the transfer of a 
second reducing equivalent to a ternary Fe(II)- 
enzyme-substrate-02 complex leads to product 
formation and regeneration of native Fe(II1) en- 
zyme. The absence of physical evidence attribut- 
able to an activated heme-oxygen complex [5] has 
left unresolved the basic mechanism of 02 cleavage 
and hydrocarbon oxygenation in the P450 mono- 
xygenase cycle. Oxidized Fe(II1) P45oCAM will also 
catalyze an ROOH-dependent hydroxylation of 
camphor without the requirement of 02 or the 
NADH redox protein components [6]. This P450 
peroxygenase type shunt offers an alternative in 
vitro pathway that may provide insight into re- 
levant states of the monoxygenase cycle [7]. Here, 
we have investigated by rapid scanning techniques 
the transient absorption spectra of P45OCAM in 
reaction with peroxy acids. The results provide the 
first complete (360-720 nm) spectral comparisons 
of P45OCAM with related heme proteins, including 
microsomal P&OLMZ [8,9], which represents a se- 
cond P450 subclass characterized by a different 
mode of monoxygenase redox transfer [lo]. 
2. EXPERIMENTAL 
Cytochrome P45ocAM was isolated [l l] from P. 
putida strain PpG 786 (ATCC 29607) and 
crystallized [12,13] from (NH&S04 solutions as 
the enzyme substrate complex. The camphor-free 
form was prepared by gel filtration [ 131 of 
chromatographically purified enzyme [ 111. Con- 
centrations were determined spectrophotometrical- 
ly at 417 nm for native enzyme, E = 
115 mM-‘.cm-‘, and at 391 nm for the 
enzyme-substrate complex, E = 102 mM_’ .cm-’ 
1lIl. 
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m-Chloroperbenzoic acid (mCPB) was syn- 
thesized from the corresponding acid [14] and 
purified by solvent extraction [8] to >97vo active 
oxygen. Peracetic acid (PA) was obtained as a 40% 
aqueous solution (FMC) and pretreated with 
catalase to remove Hz02 [15]. Both peracids were 
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Fig.1. Soret absorption spectra of Fe(II1) P4SO CAM reacted with mCPB. (Left) Native low-spin enzyme, Initial 
conditions after mixing: 50 mM KPi, pH 7.0 (cc = 0.11); P4501mCPB (mM) was - (A) 0.0040/0.025; (B) 0.0047/0.013; 
(C) 0.~7/0.02~ (D) O.~/O.l~ (E) 0.0047/0.25. Enzyme spectrum recorded after mixing with HzO. Decreasing 
420 nm absorbance corresponds to increasing reaction time. Reaction times in ms are given in the figure; temp., 20.0 f 
0.2”C. (Right) High-spin enzyme-substrate complex. Initial conditions after mixing: 50 mM KPi, pH 7.0 (U = 0.11) 
plus 0.2 mM D - (+) camphor; 0.0093 mM P450; mCPB was (mM) - (A) 1.94; (B) 1.45; (C) 0.96; (D) 0.48; (E) 0.36; 
(F) 0.24; (0) 0.12. Enzyme-substrate difference spectrum produced by computer subtraction of two absolute spectra 
measured after mixing with HzO. Decreasing 390 nm absorbance corresponds to increasing reaction time. Initial 
reaction time and subsequent ime intervals I in ms are given in the figure; temp., 20.0 + 0.2T. 
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dissolved in Hz0 and standardized spec- 
trophotometrically at 353 nm in the HRP catalyz- 
ed triiodide assay, using E = 25.5 mM-‘.cm-’ 
Absorption spectra (360-720 nm) were con- 
strutted from 15 nm overlaps of separate 95 nm 
intervals. Maxima and isosbestic wavelengths were 
[ 161. All solutions in this study were prepared 
aerobically with multidistilled Hz0 [ 171. 
Normal absorption spectra were determined 
with a Cary 219 spectrophotometer. Rapid reac- 
tion spectra were measured on a Union Giken 
RA-601 stopped-flow spectrophotometer [ 181. 
Transient changes in light intensity after mixing 
reproducible to within a + 1 nm limit and were 
of the 
were detected by a multi-channel photodiode array 
at 95 nm/ms and stored in a Sord M223 computer. 
Ratio-log intensities and spectral subtractions 
were computed and displayed on an X-Y plotter. 
calibrated from absorption maxima 
unreacted states [ 111. 
3. RESULTS 
Consecutive Soret absorption spectra of both 
the native enzyme and the enzyme-substrate com- 
plex reacted with mCPB are shown in fig.1. The 
spectra describe reaction sequences that ultimately 
produce a bleaching of absorption (not shown), 
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Fig.2. Absorption spectra of native low-spin P450 CAM enzyme reacted with mCPB. Initial conditions after mixing: 
0.012 mM P450 (Soret region) or 0.018 mM P450 (visible region), 0.26 mM mCPB. All other conditions are given in 
fig. 1 (left). 
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which is consistent with heme destruction. Prior to 
this decay process, the data in fig. 1 illustrate spec- 
tral transformations of the Fe(II1) proteins that are 
marked by isosbestic positions over selected time 
intervals. 
Soret spectra of the reaction between mCPB and 
native low-spin enzyme (fig.1, left) are biphasic. 
The first phase is characterized by a progressive 
decrease in intensity at the 417 nm Soret max- 
imum. The second is characterized by a spectral 
transformation marked by a 411 nm isosbestic 
wavelength which results in a blue-shifted Soret 
maximum at 405 nm. Absorption spectra over the 
380-720 nm region in fig.2 are given to represent 
the essential features of this reaction. Since the 
reaction phases are not well-resolved, the spectra 
at 9 and 49 ms are only intended to indicate 
qualitatively the properties of the two intermediate 
states. The visible spectrum corresponding to the 
initial phase (9 ms) is characterized by an increased 
absorption above 600 nm with a weak maximum at 
690 nm. In contrast, the spectrum of the later 
phase (49 ms) is marked by a decrease of the 
690 nm band. 
Reaction of mCPB with the high-spin 
enzyme-camphor complex produced spectra 
(fig.1, right) characterized by a red-shift from the 
391 nm Soret maximum of the unreacted state. 
The spectral changes are dependent on [mCPB], as 
seen at the limits in fig. 1. At the lowest [mCPB], 
a spectral transformation of the enzyme-substrate 
complex is described by an isosbestic wavelength at 
408 nm. At the highest peracid concentration, the 
spectral transformation is now characterized by a 
421 nm isosbestic point that is not coincident with 
the enzyme-substrate spectrum (i.e., the baseline 
in the difference mode). 
Preliminary studies in the Soret region of native 
enzyme reacted with PA showed spectral changes 
in the early phase that are similar to the initial 
transformation with mCPB (fig.2, at 9 ms). 
However, the later and dominant phase of reaction 
is characterized by a bleaching process that masks 
any detailed analysis of the spectra. 
4. DISCUSSION 
The simplest scheme describing the reactions of 
Fe(II1) P45OCAM with mCPB requires at least two 
spectral intermediates of differing stability and 
time constant. Spectra of low-spin native enzyme 
in fig.2 provide clear evidence of at least two dif- 
ferent types of intermediates. Spectra of the high- 
spin enzyme-substrate complex are also consistent 
with at least two transient species, as indicated in 
fig. 1 by the loss of a transformation that maintains 
an isosbestic wavelength with the initial state. 
The results of the native low-spin enzyme are 
comparable to the microsomal P450~~z system [S] 
in the number of transient species detected and in 
the type of changes in the Soret region during the 
initial phase of reaction. However, whereas the 
P45OcAM transformation from the first to second 
species (fig.2) is characterized by a Soret blue- 
shift, the opposite is true for the analogous conver- 
sion of complex C to D in P450~~2 [8]. These 
results may reflect different pathways in turnover 
and/or heme destruction between crystallized 
P45OcAM and lipid-solubilized P450LMz. 
The well-documented reactions of ROOH with 
related b-type heme proteins (e.g., HRP [19,20], 
CCP [21,22] and CPO [23] and catalase [IS]) are 
characterized by intermediates corresponding to 
two oxidizing equivalents above the native Fe(II1) 
proteins. In general these states are formally 
described by an Fe(IV) heme-oxygen compound, 
with a second oxidizing equivalent localized as a 
free radical on either the porphyrin or a protein 
residue. Direct spectral comparisons between these 
intermediates and P45OCAM are viewed with cau- 
tion since there are distinct spectroscopic dif- 
ferences in the initial Fe(II1) states. However, spec- 
tral trends are apparent in this study and are 
similar to these related systems. Intermediates that 
are represented by the porphyrin radical formalism 
[18-20,231 are characterized by a Soret intensity 
nearly half that of the initial Fe(II1) state and a 
broad visible spectrum with a weak absorption in 
the 650-700 nm region. Spectral parameters of 
this type are similar to the 9 ms reaction spectrum 
of native enzyme and suggest a related electronic 
StrUCtUre in P45oCAh.1. When the radical species is 
either localized on a protein residue [21,22] or ab- 
sent [19], the Fe(IV) heme-oxygen compound is 
described by a red-shift of the Soret band from the 
initial Fe(II1) state and resolved cu/p structure in 
the 530-560 nm region. The visible region of the 
49 ms reaction spectrum with native enzyme in- 
dicates a weak correspondence to this type of in- 
termediate, although the blue-shifted Soret max- 
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imum is anomalous in this comparison. A strong 
red-shift of the Soret band from the initial Fe(II1) 
state is, however, apparent in the reaction with the 
enzyme-substrate complex. Allowing for the 
noted differences, an assignment of higher Fe(IV) 
oxidation Stab3 to intermediates of the P45oCAM 
peroxygenase-shunt remains as a plausible inter- 
pretation of the spectra here. 
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